Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT04817215 · UNKNOWN

Trial details

NCT number: NCT04817215
Sponsor: King Hamad University Hospital, Bahrain
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2021-10-01
Primary completion: 2022-04-01
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.